Elucidating the estrogen-like effects and biocompatibility of the herbal components in the Qing' E formula

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.

Jacques Genest, Jiří Fröhlich, George Fodor et al. · PubMed · 2003 · 346 citations · Full text

Medicine, Chronic Disease Prevention, Geriatric Medicine +16

Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review

Eric S. Freedland · Nutrition & Metabolism · 2004 · 298 citations · Full text

Medicine, Nutrition, Physiology +17

Coactivator AIB1 links estrogen receptor transcriptional activity and stability

Wenlin Shao, Erika Krasnickas Keeton, Donald P. McDonnell et al. · Proceedings of the National Academy of Sciences · 2004 · 131 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Drug development from natural products: exploiting synergistic effects.

G Ulrich‐Merzenich, Darius Panek, H. Zeitler et al. · PubMed · 2010 · 121 citations

Pharmacy, Pharmacology, Plant Sciences +17